Investigating how a protein affects brain cell interactions in Alzheimer's and related diseases

ApoE, lipid and immune mechanisms of human neurons and glia

NIH-funded research Mclean Hospital · NIH-10590145

This study is looking at how a protein called APOE affects brain cells and their support cells when there are issues with fats and inflammation, which can happen in diseases like Alzheimer's and Parkinson's, to help find new ways to treat these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMclean Hospital NIH-funded
Lab location1 site (Belmont, United States)
Project IDNIH-10590145 on NIH RePORTER

What this research studies

This research focuses on understanding the role of apolipoprotein E (APOE) in the interactions between neurons and glial cells, particularly in the context of lipid imbalances and inflammation associated with neurodegenerative diseases like Alzheimer's, Parkinson's, and Lewy body dementia. By utilizing advanced human stem cell models, the study aims to uncover how APOE influences cellular responses to these stressors, which could lead to better insights into the mechanisms of brain degeneration. The research will explore how disruptions in lipid transport and inflammatory responses contribute to the progression of these diseases, potentially identifying new therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease, Parkinson's disease, or Lewy body dementia.

Not a fit: Patients with neurodegenerative diseases unrelated to lipid metabolism or inflammation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease and other neurodegenerative conditions.

How similar studies have performed: Previous research has shown promising results in understanding the role of APOE in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Belmont, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.